A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer

NCT01597921 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2012-08-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of topical R1 and R2 for prophylaxis of acute radiation dermatitis in patients with breast cancer receiving radiotherapy.

Conditions

Sponsors & Collaborators

  • Water-Jel

    lead INDUSTRY

Principal Investigators

  • Merav Ben David · La Sheba Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01597921 on ClinicalTrials.gov